Control approach to cell reprogramming

US10672501B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10672501-B2
Application numberUS-201715678142-A
CountryUS
Kind codeB2
Filing dateAug 16, 2017
Priority dateAug 19, 2016
Publication dateJun 2, 2020
Grant dateJun 2, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

A method is presented for reprogramming cells of a subject. As a starting point, a biological sample of a sample cell is received from the subject, where the sample cell has a given cell type. The method includes: determining gene expression data for the sample cell from the biological sample; receiving gene expression data for a target cell having a target cell type, where the target cell type differs from the given cell type; deriving a state transition matrix which models cell dynamics; computing a regulatory set for a given transcription factor, where the regulatory set quantifies influence of the given transcription factor on a genome; expressing reprogramming of the sample cell to the target cell with a state-space representation of a linear system; and solving for the input vector in the state-space representation.

First claim

Opening claim text (preview).

What is claimed is: 1. A method for reprogramming cells of a subject, comprising: receiving a biological sample of a sample cell from the subject, where the sample cell has a given cell type; determining gene expression data for the sample cell from the biological sample; receiving gene expression data for a target cell having a target cell type, where the target cell type differs from the given cell type; deriving a state transition matrix which models cell dynamics; computing a regulatory set for a given transcription factor, where the regulatory set quantifies influence of the given transcription factor on a genome; expressing reprogramming of the sample cell to the target cell with a state-space representation of a linear system, where the gene expression data for the target cell serves as an output vector in the state-space representation, the gene expression data for the sample cell serves as a state vector in the state-space representation, the regulatory set for the given transcription factor serves as an input matrix in the state-space representation, and an input vector in the state-space representation represents the given transcription factor; solving for the input vector in the state-space representation; and introducing the given transcription factor into a particular cell of the subject, where the particular cell has the given cell type. 2. The method of claim 1 wherein determining gene expression data for the cell includes grouping genes within same topologically associated domains; and forming the state vector from the grouped genes. 3. The method of claim 2 further comprises grouping genes within same topologically associated domains using chromosome conformation capture techniques. 4. The method of claim 1 wherein the gene expression data for the sample cell is further defined as RNA-seq data. 5. The method of claim 1 wherein computing a regulatory set for a given transcription factor further comprises computing a regulator set for each of a plurality of transcription factors and joining the plurality of regulatory sets to form the input matrix. 6. The method claim 1 wherein solving for the input vector further comprises determining values for the input vector that minimize distance between the sample cell and the target cell. 7. The method of claim 6 further comprises determining values for the input vector using a least squares method. 8. The method of claim 1 wherein expressing reprogramming of the sample cell includes defining the state-space representation at two or more discrete times, where the two or more discrete times signify different points in a cell cycle and the given transcription factor can be introduced into a cell at any of the two or more discrete times. 9. The method of claim 8 wherein solving for the input vector further comprises identifying a subset of transcription factors, determining each possible sequence in which the transcription factors in the subset of transcription factors can be introduced into a cell, and solving for the input vector for each possible sequence of transcription factors in the subset of transcription factors. 10. A method for reprogramming cells of a subject, comprising: determining gene expression data for a sample cell from the subject by grouping genes within same topologically associated domains, where the sample cell has a given cell type; determining gene expression data for a target cell having a target cell type, where the target cell type differs from the given cell type; deriving a state transition matrix which models cell dynamics; computing a regulatory set for a given transcription factor, where the regulatory set quantifies influence of the given transcription factor on a genome; expressing reprogramming of the sample cell to the target cell with a state-space representation of a linear system, where the gene expression data for the target cell serves as an output vector in the state-space representation, the gene expression data for the sample cell serves as a state vector in the state-space representation, the regulatory set for the given transcription factor serves as an input matrix in the state-space representation, and an input vector in the state-space representation represents the given transcription factor; solving for the input vector in the state-space representation by determining values for the input vector that minimize distance between the sample cell and the target cell; and introducing the given transcription factor into a particular cell of the subject, where the particular cell has the given cell type. 11. The method of claim 10 further comprises grouping genes within same topologically associated domains using chromosome conformation capture techniques. 12. The method of claim 10 wherein the gene expression data for the sample cell is further defined as RNA-seq data. 13. The method of claim 10 wherein computing a regulatory set for a given transcription factor further comprises computing a regulator set for each of a plurality of transcription factors and joining the plurality of regulatory sets to form the input matrix. 14. The method of claim 10 wherein expressing reprogramming of the sample cell includes defining the state-space representation at two or more discrete times, where the two or more discrete times signify different points in a cell cycle and the given transcription factor can be introduced into a cell at any of the two or more discrete times. 15. The method of claim 14 wherein solving for the input vector further comprises identifying a subset of transcription factors, determining each possible sequence in which the transcription factors in the subset of transcription factors can be introduced into a cell, and solving for the input vector for each possible sequence of transcription factors in the subset of transcription factors.

Assignees

Inventors

Classifications

  • Transcription factors · CPC title

  • from epidermal cells, from skin cells, from oral mucosa cells · CPC title

  • ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression · CPC title

  • G16B5/00Primary

    ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks · CPC title

  • for tissue or cell typing, e.g. human leukocyte antigen [HLA] probes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10672501B2 cover?
A method is presented for reprogramming cells of a subject. As a starting point, a biological sample of a sample cell is received from the subject, where the sample cell has a given cell type. The method includes: determining gene expression data for the sample cell from the biological sample; receiving gene expression data for a target cell having a target cell type, where the target cell type…
Who is the assignee on this patent?
Univ Michigan Regents
What technology area does this patent fall under?
Primary CPC classification G16B5/00. Mapped technology areas include Physics.
When was this patent published?
Publication date Tue Jun 02 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).